BioSpace News Archive

BioMidwest

CancerVax Universal Cancer Vaccine Being Developed by UCLA

CancerVAX, Inc. announced that its sponsored research program with the University of California Los Angeles to research and develop a universal cancer vaccine is now fully under way.

March 17, 2023
·
3 min read
DermaSensor Unveils Study Results Demonstrating Ability to Detect Skin Cancer With Device Granted FDA Breakthrough Designation

DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin lesions, presented a pooled analysis today from two clinical studies evaluating the performance of the company’s device in detecting skin cancer.

March 17, 2023
·
4 min read
Deals

GENETWORx Looking to acquire or partner with Diagnostic Laboratories

GENETWORx, a private equity backed laboratory, announces it’s looking to buy or partner with other diagnostics laboratories.

March 17, 2023
·
2 min read
Celyad Oncology to announce full year 2022 financial results and host conference call

Celyad Oncology announced that the Company will report full year 2022 financial and operating results on the evening of Thursday, March 23rd.

March 17, 2023
·
4 min read
Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 Million

Defence Therapeutics Inc. (CSE: DTC) (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies

March 17, 2023
·
4 min read
Lone Star Bio

Aeglea BioTherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 17, 2023

Aeglea BioTherapeutics, Inc. announced the company granted non-qualified equity awards to four new employees with a grant date of March 17, 2023, as equity inducement awards outside of the company’s 2016 Equity Incentive Plan, but under the terms of the company’s 2018 Equity Inducement Plan.

March 17, 2023
·
2 min read